Published in Surg Endosc on July 25, 2009
Laparoscopic Revision Gastric Bypass for Weight Recidivism (WR) | NCT01040572
Laparoscopic Revision Gastric Bypass for Inadequate Initial Weight Loss (IIWL) | NCT01040377
Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin Gastroenterol Hepatol (2010) 1.60
Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. World J Gastrointest Endosc (2015) 1.08
Abdominal pain after gastric bypass: suspects and solutions. Am J Surg (2011) 1.05
Current status of endoluminal bariatric procedures for primary and revision indications. Gastrointest Endosc Clin N Am (2011) 0.98
Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass. Surg Endosc (2011) 0.96
Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc (2011) 0.90
Comparison of a superficial suturing device with a full-thickness suturing device for transoral outlet reduction (with videos). Gastrointest Endosc (2014) 0.87
Early results of trans-oral endoscopic plication and revision of the gastric pouch and stoma following Roux-en-Y gastric bypass surgery. JSLS (2010) 0.87
Gastric pouch reduction using StomaphyX in post Roux-en-Y gastric bypass patients does not result in sustained weight loss: a retrospective analysis. Surg Endosc (2013) 0.84
Impact of gastrojejunostomy diameter on long-term weight loss following laparoscopic gastric bypass: a follow-up study. Surg Endosc (2010) 0.83
Obesity and bariatrics for the endoscopist: new techniques. Therap Adv Gastroenterol (2011) 0.83
Single access laparoscopic surgery: Complementary or alternative to NOTES? World J Gastrointest Surg (2010) 0.81
Endoscopic revision of gastric bypass: Holy Grail or Epic fail? Surg Endosc (2015) 0.79
Transoral surgery for morbid obesity. World J Gastrointest Endosc (2011) 0.78
Using the StomaphyX(TM) endoplicator to treat a gastric bypass complication. JSLS (2011) 0.77
Management of Failed Laparoscopic Roux-en-Y Gastric Bypass. Bariatr Surg Pract Patient Care (2014) 0.77
Revisional Laparoscopic Gastric Pouch Resizing for Inadequate Weight Loss After Roux-en-Y Gastric Bypass. Obes Surg (2015) 0.76
Endoscopy after bariatric surgery. Ann Gastroenterol (2016) 0.75
Endoscopic revision (StomaphyX) versus formal surgical revision (gastric bypass) for failed vertical band gastroplasty. J Obes (2013) 0.75
Endoscopic gastric pouch plication - a novel endoluminal incision free approach to revisional bariatric surgery. J Surg Case Rep (2010) 0.75
Endoscopic Approach for Major Complications of Bariatric Surgery. Clin Endosc (2016) 0.75
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg (2000) 4.05
Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg (2006) 3.19
Gastric bypass for treating severe obesity. Am J Clin Nutr (1992) 1.63
Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patients. Obes Surg (2002) 1.32
Gastric surgery for morbid obesity. Complications and long-term weight control. Arch Surg (1989) 1.24
Laparoscopic revision of bariatric procedures: is it feasible? Am Surg (2005) 1.05
Endoscopic suturing for gastroesophageal reflux disease: clinical outcome with the Bard EndoCinch. Gastrointest Endosc Clin N Am (2003) 0.97
A case-match analysis of failed prior bariatric procedures converted to resectional gastric bypass. Am J Surg (2004) 0.88
Revisional bariatric surgery--potentially safe and effective. Surg Obes Relat Dis (2005) 0.87
Surgical manipulation and the tensile strength of polypropylene sutures. Arch Surg (1989) 0.80
Chronic loading and extension increases the acute breaking strength of polypropylene sutures. Ann Vasc Surg (1998) 0.79
Some mechanical properties of polypropylene sutures: relationship to the use of polypropylene in vascular surgery. J Surg Res (1988) 0.79
Collagen content, histology, and tensile strength: determinants of wound repair in various gastric stapling devices in a canine gastric partition model. J Surg Res (1987) 0.75
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One (2011) 1.60
Natural-orifice transgastric endoscopic peritoneoscopy in humans: Initial clinical trial. Surg Endosc (2007) 1.44
Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol (2010) 1.33
T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes (2013) 1.27
Dermal excisional wound healing in pigs following treatment with topically applied pure oxygen. Mutat Res (2005) 1.16
Transgastric instrumentation and bacterial contamination of the peritoneal cavity. Surg Endosc (2007) 1.14
Current national practice patterns for inpatient management of ventral abdominal wall hernia in the United States. Surg Endosc (2013) 1.13
A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes (2012) 1.13
Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy. J Am Coll Surg (2011) 1.12
Result of a national audit of bariatric surgery performed at academic centers: a 2004 University HealthSystem Consortium Benchmarking Project. Arch Surg (2006) 1.10
New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC. Inflamm Bowel Dis (2009) 1.09
Transgastric endoscopic peritoneoscopy does not require decontamination of the stomach in humans. Surg Endosc (2008) 1.06
Barbed suture for gastrointestinal closure: a randomized control trial. Surg Innov (2009) 1.06
Operative and nonoperative management of pancreatic pseudocysts. Surg Clin North Am (2007) 1.04
Advanced endoscopic technologies. Surg Endosc (2008) 1.02
Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford) (2010) 1.02
Robotic and laparoscopic pancreaticoduodenectomy: a hybrid approach. Pancreas (2010) 1.01
Lubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestine. Dig Dis Sci (2010) 1.00
Diagnostic transgastric endoscopic peritoneoscopy: extension of the initial human trial for staging of pancreatic head masses. Surg Endosc (2010) 0.97
A comparison of outcomes between open and laparoscopic surgical repair of recurrent inguinal hernias. Surg Endosc (2011) 0.97
Robot-assisted general surgery. Semin Laparosc Surg (2004) 0.97
Why fundamentals of endoscopic surgery (FES)? Surg Endosc (2013) 0.95
Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature. Surg Endosc (2013) 0.95
Eye motion parameters correlate with level of experience in video-assisted surgery: objective testing of three tasks. J Laparoendosc Adv Surg Tech A (2005) 0.91
Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection. Pancreas (2006) 0.91
Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population. Surg Endosc (2010) 0.89
Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer. J Gastrointest Surg (2009) 0.89
Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation. Obes Surg (2007) 0.88
2014 SSAT State-of-the-Art Conference: advances in diagnosis and management of gastroesophageal reflux disease. J Gastrointest Surg (2014) 0.88
Pain and wound healing in surgical patients. Ann Behav Med (2006) 0.88
Clinical factors predictive of malignant and premalignant cystic neoplasms of the pancreas: a single institution experience. HPB (Oxford) (2009) 0.87
Gastrotomy closure using bioabsorbable plugs in a canine model. Surg Endosc (2007) 0.87
The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner. Biochemistry (2004) 0.87
A review of 130 humans enrolled in transgastric NOTES protocols at a single institution. Surg Endosc (2010) 0.87
Near-infrared fluorescent cholangiography facilitates identification of biliary anatomy during laparoscopic cholecystectomy. Surg Endosc (2014) 0.87
Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease. Ann Surg Oncol (2010) 0.86
Omental patch repair effectively treats perforated marginal ulcer following Roux-en-Y gastric bypass. Surg Endosc (2012) 0.86
A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth. J Gastrointest Surg (2006) 0.86
Gastric ischemic conditioning increases neovascularization and reduces inflammation and fibrosis during gastroesophageal anastomotic healing. Surg Endosc (2012) 0.85
Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2005) 0.85
Delivery of radiofrequency energy to the lower esophageal sphincter improves symptoms of gastroesophageal reflux. Surgery (2004) 0.85
Laparoscopic distal pancreatectomy with splenic conservation: an operation without increased morbidity. Gastroenterol Res Pract (2009) 0.85
Stromal osteonectin overexpression is associated with poor outcome in patients with ampullary cancer. Ann Surg Oncol (2006) 0.84
Frequent p16INK4A/CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors. Carcinogenesis (2003) 0.84
50-year appraisal of gastrinoma: recommendations for staging and treatment. J Am Coll Surg (2006) 0.83
CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance. Obesity (Silver Spring) (2014) 0.83
Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A). Biochemistry (2005) 0.83
Endolumenal fundoplication with EsophyX: the initial North American experience. Surg Innov (2008) 0.82
Safe alternative transgastric peritoneal access in humans: NOTES. Surgery (2010) 0.82
Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication. J Laparoendosc Adv Surg Tech A (2013) 0.82
Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience. Surg Endosc (2014) 0.81
Efficacy and durability of robotic Heller myotomy for achalasia: patient symptoms and satisfaction at long-term follow-up. Surg Endosc (2014) 0.81
Expression and characterization of Syrian golden hamster p16, a homologue of human tumor suppressor p16 INK4A. Biochem Biophys Res Commun (2003) 0.81
Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Ann Surg Oncol (2009) 0.81
A computerized analysis of robotic versus laparoscopic task performance. Surg Endosc (2007) 0.80
Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center. Surg Endosc (2014) 0.79
Evolution of minimally invasive bariatric surgery. Surgery (2002) 0.79
Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) does not provide long-term symptom control. Surg Innov (2008) 0.78
Natural orifice translumenal endoscopic surgery. Surg Clin North Am (2008) 0.78
Reactive oxygen species and EGR-1 gene expression in surgical postoperative peritoneal adhesions. World J Surg (2004) 0.78
Gastrectomy in advanced gastric cancer effectively palliates symptoms and may improve survival in select patients. J Gastrointest Surg (2014) 0.78
Novel reconstruction of the extrahepatic biliary tree with a biosynthetic absorbable graft. HPB (Oxford) (2011) 0.78
Evolution of the laparoscopic gastric bypass. J Laparoendosc Adv Surg Tech A (2003) 0.78
Differential gene expression in patients genetically predisposed to pancreatic cancer. J Surg Res (2006) 0.77
Telerobotic foregut and esophageal surgery. Surg Clin North Am (2003) 0.77
Pheochromocytoma does not increase risk in laparoscopic adrenalectomy. Surg Endosc (2010) 0.76
Computer-assisted robotic antireflux surgery. Surg Laparosc Endosc Percutan Tech (2002) 0.76
Endoscopic peritoneal access and insufflation: natural orifice transluminal endoscopic surgery. Gastrointest Endosc (2009) 0.75
Perioperative outcomes of laparoscopic transhiatal esophagectomy with antegrade esophageal inversion for high-grade dysplasia and invasive esophageal cancer. Surgery (2013) 0.75
Do gastrotomies require repair after endoscopic transgastric peritoneoscopy? A controlled study. Gastrointest Endosc (2010) 0.75
Successful management of chyloperitoneum after laparoscopic adjustable gastric banding in 2 patients. Surg Obes Relat Dis (2010) 0.75
Unexpected gastrointestinal tract conditions. Curr Probl Surg (2006) 0.75
A retained foreign body mimicking colon cancer. Surg Laparosc Endosc Percutan Tech (2012) 0.75
Current Concepts and Controversies in Foregut Motility: the 2012 Kelly and Carlos Pellegrini SSAT/SAGES Joint Symposium. J Gastrointest Surg (2013) 0.75